Does PPD have a direct stock purchase plan or a dividend reinvestment program (DRIP)?
No, PPD does not have a direct stock purchase plan or a dividend reinvestment program.
How do I change my address on the PPD stock certificate, change title of the stock or report lost stock certificates?
All inquiries regarding ownership of PPD stock should be directed to PPD's transfer agent and registrar, American Stock Transfer & Trust Company located at 6201 15th Avenue, Brooklyn, NY 11219.
The toll-free number is +800 937 5449; the worldwide telephone number is +718 921 8124.
What is a direct registration system (DRS)?
PPD's common stock is now direct registration system (DRS) eligible. DRS is a method of recording shares of stock in book-entry form through PPD's transfer agent, American Stock Transfer and Trust Company. This eliminates the need for physical share certificates. Read additional information about the benefits of DRS (Adobe Acrobat file, 322 Kb).
When does the PPD fiscal year end?
31 December.
When was PPD founded and in what state was it incorporated?
PPD was founded in 1985. The company was incorporated in January 1989 in North Carolina.
When did PPD become a publicly traded company, and at what price?
PPD went public on 24 January 1996 at an initial price of $18.00 USD.
How many people work at PPD?
PPD has more than 10,400 professionals in 68 offices and 31 countries around the world.
How many shares of PPD stock are outstanding?
As of 20 March 2008, there were 119,617,093 shares of PPD common stock outstanding.
How much PPD stock is held by insiders?
As of 20 March 2008, PPD directors and current executive officers owned approximately 10.7 percent of the outstanding common stock.
What percentage of PPD business is international?
For the year ended 31 December 2007, approximately 34 percent of PPD revenues were generated from services provided by our employees located in countries outside of North America.
Who are the independent auditors for PPD?
The independent registered public accounting firm for PPD is Deloitte & Touche LLP (Raleigh, NC).
Who are other major providers of services in the industry?
Quintiles (QTRN), Covance (CVD), PAREXEL (PRXL), Kendle (KNDL) and ICON (ICLR) are other major providers in the industry. Some companies compete for many of the service offerings for drug development, but PPD is unique in providing discovery, development and post-approval services as well as compound partnering programs.
What services does PPD offer?
No other single company is more involved in providing both discovery and development support to pharmaceutical, biotechnology, medical device, academic and government organizations. Please refer to our Web site, www.ppdi.com, for more information on PPD's expansive portfolio of capabilities for discovery sciences/compound partnering and development services.
What are some of the cost-saving practices used by PPD?
The frugal company culture at PPD emphasizes strong fiscal responsibility in every aspect of our operations. Expenses are budgeted at conservative levels and are monitored on a regular basis to ensure adherence to plan. All PPD employees are encouraged to obtain the best value for the dollar for the company and our customers.
How long has Fred Eshelman been with PPD? What is his background?
Fred Eshelman, Pharm.D., is the founder and chief executive officer of PPD, the company he established as a one-person consulting firm in 1985. His career has included positions as senior vice president of development and vice president of clinical operations for the former Glaxo, Inc., as well as various roles in drug development with other pharmaceutical companies.
Dr. Eshelman received his doctorate in pharmacy from the University of Cincinnati and a bachelor's degree in pharmacy from the University of North Carolina at Chapel Hill. He is a graduate of the Owner President Management (OPM) program at Harvard Business School.
show all
hide all
0.48
